FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Prostate cancer mortality is significantly reduced when docetaxel is used.

2.

No Solace From Drug Scarcities; Novel Guidelines Regarding Lymphedema; A "Good" Patient Is Forgotten.

3.

The pancreatic ductal adenocarcinoma mRNA vaccine holds promise for preventing relapse.

4.

Radiation from CT scans could account for 5% of all cancer cases a year, study suggests

5.

Early-life exposure to air and light pollution linked to increased risk of pediatric thyroid cancer


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot